Structural basis of Zika virus helicase in recognizing its substrates
- 5k Downloads
- 27 Citations
Abstract
The recent explosive outbreak of Zika virus (ZIKV) infection has been reported in South and Central America and the Caribbean. Neonatal microcephaly associated with ZIKV infection has already caused a public health emergency of international concern. No specific vaccines or drugs are currently available to treat ZIKV infection. The ZIKV helicase, which plays a pivotal role in viral RNA replication, is an attractive target for therapy. We determined the crystal structures of ZIKV helicase-ATP-Mn2+ and ZIKV helicase-RNA. This is the first structure of any flavivirus helicase bound to ATP. Comparisons with related flavivirus helicases have shown that although the critical P-loop in the active site has variable conformations among different species, it adopts an identical mode to recognize ATP/Mn2+. The structure of ZIKV helicase-RNA has revealed that upon RNA binding, rotations of the motor domains can cause significant conformational changes. Strikingly, although ZIKV and dengue virus (DENV) apo-helicases share conserved residues for RNA binding, their different manners of motor domain rotations result in distinct individual modes for RNA recognition. It suggests that flavivirus helicases could have evolved a conserved engine to convert chemical energy from nucleoside triphosphate to mechanical energy for RNA unwinding, but different motor domain rotations result in variable RNA recognition modes to adapt to individual viral replication.
Keywords
Zika virus helicase ATP crystal structure flavivirusIntroduction
Zika virus (ZIKV) belongs to the Flavivirus genus which contains important human pathogens such as dengue (DENV), yellow fever (YFV), West Nile (WNV), Japanese encephalitis (JEV) and tick-borne encephalitis (TBEV) viruses (Pierson and Diamond, 2013). ZIKV was first isolated in 1947 from a febrile sentinel rhesus monkey in the Zika forest of Uganda (Wikan and Smith, 2016). As an arthropod-borne flavivirus, ZIKV is transmitted by multiple Aedes mosquitoes (Dick et al., 1952). Typically, human infection by ZIKV caused a mild and self-limiting illness, characterized with fever, headache, arthralgia, myalgia, and maculopapular rash (Ioos et al., 2014). In April 2007, a large epidemic of Asian genotype ZIKV broke out in Yap Island and Guam, Micronesia, bringing ZIKV to global attention (Duffy et al., 2009; Haddow et al., 2012). From 2013 to 2014, the Asian genotype was also confirmed as the culprit for numerous epidemics among several Pacific Islands, including French Polynesia, New Caledonia, Cook Islands, Tahiti, and Easter Island (Lazear and Diamond, 2016). In 2015, widespread ZIKV infection was reported in Brazil and other parts of South America, with an estimated case counts of 1.3 million cases (Hennessey et al., 2016; Mlakar et al., 2016). Recent studies showed that ZIKV was identified in fetal brain tissue, presumably accounting for the sharp increase of congenital microcephaly in the epidemic areas (Brasil et al., 2016; Mlakar et al., 2016; Rodrigues, 2016). Upon ZIKV infection, significant cellular death of neural stem cells was shown to be responsible for the inhibitory role of ZIKV on fetal brain development (Tang et al., 2016). However, no effective vaccines or therapies are currently available to prevent or treat ZIKV infection. With the increasing case numbers and potential risk of global spread, ZIKV is becoming a great challenge to the public health of the Western Hemisphere as well as the whole world (Lazear and Diamond, 2016).
The genome of ZIKV is composed of a positive-sense single strand RNA. Viral replication begins with the translation of its RNA genome into a large polypeptide, which is then proteolytically cleaved into 3 structural proteins (C, prM/M, and E), and 7 non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) (Pierson and Diamond, 2013). The NS3 protein plays an essential role in viral polypeptide processing and genomic replication, with a protease domain at its N-terminus and a helicase domain at the C-terminus. Upon RNA binding, the helicase domain exhibits intrinsic nucleoside triphosphatase activity, which then provides the chemical energy to unwind viral RNA replication intermediates to facilitate replication of the viral genome together with RNA-dependent RNA polymerase (NS5) (Lindenbach and Rice, 2001). Given its essential role in genome replication, ZIKV helicase could be an attractive target for drug development against ZIKV (Noble et al., 2010). Recently, we have reported the apo-helicase of ZIKV (Tian et al., 2016), but the mechanisms of how ZIKV helicase recognizes nucleoside triphosphate and viral RNA is still largely unknown, hindering the development of antiviral drugs. Here we report the crystal structures of ZIKV helicase-ATP-Mn2+ and ZIKV helicase-RNA, which help elucidate how ZIKV recognizes its substrates during replication and provide structural insight for rational drug design.
Results and discussion
ATP hydrolysis and RNA unwinding assays
The ATPase and RNA unwinding activities of ZIKV helicase. (A) Determination of ATP hydrolysis activity of ZIKV helicase. The ATPase assay was carried out with 20 nmol/L of enzyme in the presence of the indicated concentrations of ATP for 20 min at 25°C. The double-reciprocal plot was fitted according to the Michaelis-Menten equation. (B) Measurement of dsRNA unwinding activity of ZIKV helicase. RNA unwinding activity of ZIKV helicase was assayed using a radiolabeled dsRNA substrate. The first lane is the positive control (heat-denatured duplex) and the second lane is the negative control (without ZIKV helicase)
Structure determination
To elucidate the molecular mechanisms of ZIKV helicase in recognizing ATP/Mn2+ and RNA, we determined the crystal structures of ZIKV helicase180–617 complexed with ATP/Mn2+ and ZIKV helicase172–617 complexed with a 7-mer RNA (5′-AGAUCAA-3′) at 2.2 Å and 1.7 Å, respectively (Table S1).
The structure of the ZIKV helicase in complex with ATP and Mn2+
Structure of the ZIKV helicase in complex with ATP/Mn 2+ . (A) Overall fold of ZIKV helicases, with cartoon representation of apo form (white) overlaid to the complex (the three domains are colored respectively). The ATP is drawn as sticks and mesh; Mn2+ as green sphere. A detailed comparison for the ATP binding sites of the two structures is depicted in the zoomed view below. (B) A close-up view of the NTPase active site. P-loops are represented by superimposition of the structures of ZIKV (white, with the P-loop highlighted in red) and DENV4 (cyan) apo-helicases in the left panel and their complexes in the right panel. The DENV4 helicase complex was bound to AMPPNP and Mn2+ (PDB code 2JLR). (C) Interactions at NTPase active site by superposition of the ZIKV helicase complexed with ATP and Mn2+ (solid) with its apo enzyme (semitransparent, PDB code 5JMT)
In the ZIKV helicase180–617-ATP-Mn2+ tertiary structure, ATP/Mn2+ are located at the cleft between Domain I and II (Fig. 2A and 2C). Substrate binding causes an inward reorientation of side-chain of K200 to stabilize the triphosphate moiety of ATP and a flipping of the side-chain of R202 towards the solvent to leave room for sugar moiety. The triphosphate moiety of ATP adopts an extended conformation as seen in DENV4 helicase in complex with AMPPNP (Luo et al., 2008). The Mn2+ ion is coordinated in an octahedral geometry by side chains of E286 (motif II) and T201, two ordered water molecules and two oxygen atoms from the β/γ phosphate groups of the ATP molecule, which stabilize the nucleoside triphosphate. The ATP molecule makes additional contacts with G197, K200, R202 (P-loop), R459, R462 (motif VI) and other ordered water molecules (Fig. 2C). Among them, K200 is responsible for interacting with the γ-phosphate of the nucleotide during transition state. The 3′-OH group of the ribose forms hydrogen bonds with the carbonyl oxygen of R462 and the side chain amide group of N330. The ribose group of ATP bulges out from the binding pocket and no clear electron densities are observed for the adenine group, suggesting that the ZIKV helicase may not have nucleotide specificity for its NTPase activity.
The structure of ZIKV helicase in complex with RNA
Overall structure
Structure of the ZIKV helicase in complex with RNA. (A) Cartoon representation of overall fold of the ZIKV helicase-RNA complex with three domains colored and marked respectively. The ssRNA is shown in orange sticks and meshes. (B) Overlay of the ZIKV helicase-RNA complex structure and its apo form (grey). The RNA is shown in orange. (C) Overlay of the DENV4 helicase-RNA complex structure and its apo form (grey). The RNA is shown in yellow. The rotations of domain II and III upon RNA binding are depicted accordingly. (D) Schematic illustration of the different modes of domain rotations for ZIKV and DENV4 helicases upon RNA binding
Conformational changes upon RNA binding
Compared with its apo-form, the ZIKV helicase undergoes obvious conformational changes, largely due to a rotation of Domain II and Domain III, once it binds to ssRNA. Domain II rotates about 9° away from Domain I in a rigid-body rotation mode along axis II in the direction as noted in Fig. 3B and 3D. However, Domain III rotates about 9° away from Domain I in the opposite direction along axis III, which is approximately parallel to axis II (Fig. 3B and 3D). This rotor domain rotation caused two α-helices (residues 365–379, and residues 390–400) in Domain II and two α-helices (residues 525–537, and residues 602–615) in Domain III to move away from the RNA binding groove in an opposite direction, enlarging the groove to accommodate the ssRNA. This natural design functions like a double-leaf swing gate with each leaf opening in a reverse direction to the other (Fig. 3B and 3D). Interestingly, the motor domain rotation mode in the ZIKV helicase is distinct from that in the DENV4 helicase structure (Luo et al., 2008). In the DENV4 helicase, the rotation axis for Domain II, however, is almost vertical to that for Domain III, but the rotation directions are identical (Fig. 3C and 3D).
RNA recognition
RNA recognition modes for ZIKV and DENV4 helicases. (A) Superposition of ZIKV (domains colored respectively) and DENV4 (white) apo-helicases. (B) Superposition of ZIKV (domains colored respectively and RNA in orange) and DENV4 (black and RNA in yellow) helicase-RNA complex. The distance between the sugar groups of nucleotide 1 in ZIKV and DENV4 helicases is marked in red. (C and D) show the conformation of subsite 1 of the ZIKV helicase-RNA complex (C) and the DENV4 helicase-RNA complex (D) in a 90° rotated view of (B). RNAs are shown in sticks and proteins are shown in ribbon with domains colored differently
Comparison of protein-RNA interactions for ZIKV and DENV4 helicases. Left panels are for ZIKV helicase-RNA complex and right panels for DENV4. (A) The electrostatic surface representations showing the tunnel for RNA binding. Positive potentials are colored blue and the negative are colored red. The nucleic acids are shown in orange (ZIKV helicase) and yellow (DENV4 helicase). (B) Interactions in RNA binding tunnels. Proteins are shown in ribbon and colored according to domains. RNAs and interacting residues from the helicases are shown in sticks. Water molecules are shown in red spheres. (C) Detailed view for the protein-ssRNA interactions
Because of its essential role for replication, a viral helicase is an attractive target whose accurate mechanism is still largely unknown. Flavivirus helicases possess nucleoside triphosphatase activity, which enables the enzyme to convert chemical energy to unwind viral RNA replication intermediates. Our structures presented here can help deepen our understanding of this process and provide structural basis for rational drug design. Interestingly, although there exists conformational variety in the NTP binding pocket of apo-helicases among different flaviviruses, they undergo conformational changes to adopt an identical mode to bind NTPs, which may result from the natural selection for the same function of hydrolyzing NTPs. On the other hand, to our surprise, although the residues are well conserved for RNA binding between different flavivirus apo-helicases, distinct rotations of motor domains would cause different manners to recognize their individual RNAs during replication. These findings suggest that flaviviruses could have evolved a conserved engine to convert chemical energy to mechanical energy, but variable RNA recognition modes to adapt to their individual replication.
Materials and methods
Cloning and expression
The cloning and expression of the ZIKV helicase172–617 (residues 172 to 617) has been described previously (Tian et al., 2016). The short form of catalytic domain180–617 (residues 180 to 617) was amplified by PCR using the forward primer 5′-CGCGGATCCGAGCCGTCAATGTTGAAG-3′ and the reverse primer 5′-CCGCTCGAGTTACCGTTTTCCGGCTGCGAA-3′. The underlined regions correspond to BamHI and XhoI sites, respectively. The coding sequence for helicase180–617 was cloned into the vector pET.32M.3C and fused at its N-terminus to thioredoxin and a (His)6 tag followed by PreScission Protease (GE) cleavage site. Transformed Escherichia coli BL21 (DE3) clones were grown in LB medium at 37°C and then induced by 0.2 mmol/L isopropyl-β-D-thiogalactopyranoside at 16°C. After overnight growth, cells were harvested via centrifugation.
Protein purification
The purification of ZIKV helicase172–617 has been described previously (Tian et al., 2016). Briefly, the Trx-(His)6-helicase172–617 was purified by Ni Sepharose (GE) affinity chromatography and cleaved with PreScission Protease, followed by anion-exchange chromatography and size exclusion chromatography. The purification of ZIKV helicase180–617 was described below. Cells resuspended in lysis buffer A (20 mmol/L Na2HPO4, pH 8.0, 0.5 mol/L NaCl and 20 mmol/L imidazole) were lysed by high pressure homogenization and the lysate was clarified by centrifugation at 30,000 ×g for 40 min at 4°C. The supernatant was purified by Ni Sepharose (GE) affinity chromatography equilibrated with buffer A. Proteins were eluted using buffer A supplemented with 250 mmol/L imidazole. After concentration by ultrafiltration and dilution in buffer B (20 mmol/L Na2HPO4, pH 8.0, 0.5 mol/L NaCl), the fraction containing Trx-(His)6-ZIKV helicase180–617 was cleaved with PreScission Protease at 4°C for approximately 12 h. The cleavage mixture of ZIKV helicase180–617 was loaded onto a HiTrap S 5 mL column (GE) pre-equilibrated with buffer C (50 mmol/L HEPES, pH 7.0, 50 mmol/L NaCl and 5% glycerol) and also eluted using a linear NaCl concentration gradient. The concentrated proteins of interest were subjected to a final gel-filtration purification step through a HiLoad 16/600 Superdex 200TM PG column (GE) in buffer D (10 mmol/L Tris-HCl, pH 8.0, 150 mmol/L NaCl, 5 mmol/L dithiothreitol and 5% glycerol).
ATPase activity assay
The ATP activity assay was carried out using the QuantiChromTM ATPase/GTPase Assay Kit (BioAssay Systems). The ZIKV helicase172–617 was preincubated at a concentration of 20 nmol/L in 20 μL assay buffer (40 mmol/L Tris, 80 mmol/L NaCl, 8 mmol/L MgAc2, 1 mmol/L EDTA, pH 7.5) in a 96-well plate. The reaction was carried out with 10 μL ATP at various concentrations for 20 min at 25°C and then terminated by adding 200 μL of reagent buffer. Followed by incubation with reagent buffer for 30 min at the room temperature, the absorbance was measured at 620 nm. The K m and k cat of the enzyme were obtained from a double-reciprocal plot with the GraphPad Prism Software.
RNA unwinding
To obtain the partial dsRNA substrate (11-nucleotide complementation) for helicase unwinding activity assay, the R1 (5′-AGCCUAAAUUUCAAUCCCG-3′) strand was labeled by using [γ-32P]ATP (3000 Ci/mmol, Perkin-Elmer) and T4 polynucleotide kinase (Thermo scientific) for 1 h at 37°C. After ethanol precipitation, the labeled R1 was annealed with the R2 (5′-CGGGAUUGAAAGGACUUAC-3′) strand by heating to 100°C in annealing buffer (10 mmol/L Tris-Cl, pH 7.5, 100 mmol/L NaCl, 1 mmol/L EDTA) and cooled down slowly to room temperature. The annealed duplex was purified by a 15% native polyacrylamide gel electrophoresis in TBE buffer (45 mmol/L Tris, 45 mmol/L boric acid, 2 mmol/L EDTA, pH 8.0) and dissolved in TE buffer to yield a 10 nmol/L substrate.
The assay was performed using 20 μL reaction mixture containing 50 mmol/L HEPES (pH 7.5), 50 mmol/L NaCl, 2.5 mmol/L MgCl2, 10 mmol/L ATP, 5 U RNase inhibitor (New England Biolabs), 0.5 nmol/L of RNA substrate and the ZIKV helicase172–617 at various concentrations or an equivalent volume of the protein storage buffer (negative control). The mixtures were incubated for 30 min at 30°C and the reactions were terminated by adding 5 μL-loading dye (0.25 mol/L EDTA, 0.5% SDS, 50% glycerol, 0.01% bromophenol blue) to the mixtures. The boil mixture (without helicase) was boiled in boiling water for 3 min then chilled on ice quickly. All these mixtures were subjected to electrophoresis using a 12% native polyacrylamide gel. The radioisotopic substrates were detected by X-OMAT BT Film (Carestream).
Crystallization
Crystals for the ATP (Sangon Biotech) complex were obtained by cocrystallization of the ZIKV helicase180–617 at a concentration of 5 mg/mL, with 5 mmol/L MnCl2 and 5 mmol/L ATP in 0.1 mol/L HEPES, pH 7.4 and 9% (w/v) polyethylene glycol 3350 at 18°C by the microbatch-under-oil method. The binary complex with ssRNA (5′-AGAUCAA-3′) was also obtained through cocrystallization. Initially, ZIKV helicase172–617 (storage buffer: buffer D) at 5 mg/mL was incubated with ssRNA (GenePharma) at 0.2 mmol/L (~2-fold molar excess) at 18°C for 1 h. Subsequently, the crystals of ZIKV helicase172–617-RNA complex were grown at 18°C by the microbatch-under-oil method and the crystallization condition contained 0.2 mol/L potassium sodium tartrate tetrahydrate pH 7.4 and 20% (w/v) polyethylene glycol 3350.
Crystal data collection, structure determination and refinement
Crystals were cryoprotected using the crystallization buffer with 30% glycerol and flash-frozen in liquid nitrogen. Diffraction data were collected at 100 K at Shanghai Synchrotron Radiation Facility (SSRF) beamLine BL19U1 at a wavelength of 0.97853 Å. Diffraction data were processed using HKL3000 (Minor and Otwinowski, 1997). Crystals for both complexes belong to space group P2 1 and the data statistics are summarized in Table S1. The structures were solved by molecular replacement using the apo structure of ZIKV helicase (PDB ID 5JMT) as a search model. The program PHASER (McCoy et al., 2007) was used for the molecular replacement search. The initial models were auto-built by Buccaneer (Cowtan, 2006) and refined through iterative rounds of TLS and restrained refinement using Refmac5 (Murshudov et al., 2011), followed by rebuilding manually using Coot (Emsley and Cowtan, 2004). The refinement statistics are summarized in Table S1.
Protein structure accession number
The refined coordinates have been deposited in the PDB under accession number 5GJB and 5GJC.
Notes
ACKNOWLEDGMENTS
We would like to thank the staff at beamLine BL18U1 and BL19U1 of the Shanghai Synchrotron Radiation Facility (SSRF) for data collection; Henry C. Nguyen and Lanfeng Wang for discussion and advice. This work was supported by the National Basic Research program of China (973 program) (Nos. 2015CB859800 and 2014CB542800) and the National Natural Science Foundation of China (Grant Nos. 31528006 and 31271331).
Hongliang Tian, Haitao Yang and Zihe Rao conceived and designed the experiments. Hongliang Tian, Xiaoyun Yang, Zhongxin Zhang, Heng Chi, Zhongyu Mu and Wei Xie performed the experiments. Xiaoyun Ji, Cheng Chen, Qi Zhao, Zefang Wang, Huiqiang Lou and Haitao Yang analyzed the data. Hongliang Tian, Xiaoyun Ji, Zuokun Lu, Kailin Yang, and Haitao Yang wrote the paper.
ABBREVIATIONS
DENV, dengue virus; JEV, Japanese encephalitis virus; TBEV, tick-borne encephalitis virus; WNV, West Nile virus; YFV, yellow fever virus; ZIKV, Zika virus.
COMPLIANCE WITH ETHICS GUIDELINES
Hongliang Tian, Xiaoyun Ji, Xiaoyun Yang, Zhongxin Zhang, Zuokun Lu, Kailin Yang, Cheng Chen, Qi Zhao, Heng Chi, Zhongyu Mu, Wei Xie, Zefang Wang, Huiqiang Lou, Haitao Yang and Zihe Rao declare that they have no conflict of interest.
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Supplementary material
REFERENCES
- Brasil P, Pereira JP Jr, Raja Gabaglia C, Damasceno L, Wakimoto M, Ribeiro Nogueira RM, Carvalho de Sequeira P, Machado Siqueira A, Abreu de Carvalho LM, Cotrim da Cunha D et al (2016) Zika virus infection in pregnant women in Rio de Janeiro—preliminary report. N Engl J Med. http://www.nejm.org/doi/10.1056/NEJMoa1602412
- Cowtan K (2006) The Buccaneer software for automated model building. 1. Tracing protein chains. Acta Crystallogr D Biol Crystallogr 62:1002–1011CrossRefPubMedGoogle Scholar
- Dick GW, Kitchen SF, Haddow AJ (1952) Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 46:509–520CrossRefPubMedGoogle Scholar
- Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS, Pretrick M, Marfel M, Holzbauer S, Dubray C et al (2009) Zika virus outbreak on Yap Island, federated states of Micronesia. N Engl J Med 360:2536–2543CrossRefPubMedGoogle Scholar
- Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60:2126–2132CrossRefPubMedGoogle Scholar
- Haddow AD, Schuh AJ, Yasuda CY, Kasper MR, Heang V, Huy R, Guzman H, Tesh RB, Weaver SC (2012) Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl Trop Dis 6:e1477CrossRefPubMedPubMedCentralGoogle Scholar
- Hennessey M, Fischer M, Staples JE (2016) Zika virus spreads to new areas—region of the Americas, May 2015–January 2016. MMWR Morb Mortal Wkly Rep 65:55–58CrossRefPubMedGoogle Scholar
- Ioos S, Mallet HP, Leparc Goffart I, Gauthier V, Cardoso T, Herida M (2014) Current Zika virus epidemiology and recent epidemics. Med Mal Infect 44:302–307CrossRefPubMedGoogle Scholar
- Lanzetta PA, Alvarez LJ, Reinach PS, Candia OA (1979) An improved assay for nanomole amounts of inorganic phosphate. Anal Biochem 100:95–97CrossRefPubMedGoogle Scholar
- Lazear HM, Diamond MS (2016) Zika virus: new clinical syndromes and its emergence in the Western Hemisphere. J Virol. doi: 10.1128/JVI.00252-16 PubMedGoogle Scholar
- Lindenbach BD, Rice CM (2001) Fundamental virology. Lippincott-Raven, Philadelphia, PAGoogle Scholar
- Luo D, Xu T, Watson RP, Scherer-Becker D, Sampath A, Jahnke W, Yeong SS, Wang CH, Lim SP, Strongin A et al (2008) Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein. EMBO J 27:3209–3219CrossRefPubMedPubMedCentralGoogle Scholar
- McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ (2007) Phaser crystallographic software. J Appl Crystallogr 40:658–674CrossRefPubMedPubMedCentralGoogle Scholar
- Minor W, Otwinowski Z (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods in enzymology volume 276: macromolecular crystallography, part A. Academic Press, New York, pp 307–326Google Scholar
- Mlakar J, Korva M, Tul N, Popovic M, Poljsak-Prijatelj M, Mraz J, Kolenc M, Resman Rus K, Vesnaver Vipotnik T, Fabjan Vodusek V et al (2016) Zika virus associated with microcephaly. N Engl J Med 374:951–958CrossRefPubMedGoogle Scholar
- Murshudov GN, Skubak P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA, Winn MD, Long F, Vagin AA (2011) REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr 67:355–367CrossRefPubMedPubMedCentralGoogle Scholar
- Noble CG, Chen YL, Dong H, Gu F, Lim SP, Schul W, Wang QY, Shi PY (2010) Strategies for development of Dengue virus inhibitors. Antiviral Res 85:450–462CrossRefPubMedGoogle Scholar
- Pierson TC, Diamond MS (2013) Flaviviruses, vol 2, 6th edn. Wolter Kluwer, PhiladelphiaGoogle Scholar
- Rodrigues LC (2016) Microcephaly and Zika virus infection. The Lancet. doi: 10.1016/S0140-6736(16)00742-X Google Scholar
- Tang H, Hammack C, Ogden SC, Wen Z, Qian X, Li Y, Yao B, Shin J, Zhang F, Lee EM et al (2016) Zika virus infects human cortical neural progenitors and attenuates their growth. Cell Stem Cell. doi: 10.1016/j.stem.2016.02.016 Google Scholar
- Tian H, Ji X, Yang X, Xie W, Yang K, Chen C, Wu C, Chi H, Mu Z, Wang Z et al (2016) The crystal structure of Zika virus helicase: basis for antiviral drug design. Protein Cell 7:450–454CrossRefPubMedPubMedCentralGoogle Scholar
- Wikan N, Smith DR (2016) Zika virus: history of a newly emerging arbovirus. Lancet Infect Dis 16:e119–e126CrossRefPubMedGoogle Scholar
Copyright information
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.